Compare ALT & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALT | SHBI |
|---|---|---|
| Founded | 1997 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 618.4M |
| IPO Year | N/A | N/A |
| Metric | ALT | SHBI |
|---|---|---|
| Price | $5.41 | $18.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $16.33 | ★ $19.17 |
| AVG Volume (30 Days) | ★ 3.5M | 212.7K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | N/A | ★ 38.21 |
| EPS | N/A | ★ 1.71 |
| Revenue | $20,000.00 | ★ $212,493,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.77 |
| P/E Ratio | ★ N/A | $11.00 |
| Revenue Growth | N/A | ★ 10.07 |
| 52 Week Low | $2.90 | $11.47 |
| 52 Week High | $9.59 | $19.22 |
| Indicator | ALT | SHBI |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 76.04 |
| Support Level | $5.03 | $17.57 |
| Resistance Level | $6.03 | $19.22 |
| Average True Range (ATR) | 0.38 | 0.40 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 53.39 | 79.44 |
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.